Safety and Efficacy of Alteplase When Administered in Chinese Patients With Acute Ischemic Hemispheric Stroke Where Thrombolysis is Initiated Between 3 and 4.5 Hours After Stroke Onset
Clinical trial NCT02930837 · COMPLETED
Trial details
- NCT number
- NCT02930837
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-15
- Primary completion
- 2017-12-11
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.